logo
Plus   Neg
Share
Email

Corcept Therapeutics Inc. (CORT) Is Down Sharply In Early Trade

Corcept Therapeutics Inc. (CORT) gapped open sharply lower Monday morning and has continued to fall in early trade. Shares are now down 6.09 at $17.37 on above average volume. The stock has tumbled to over a 1-month low.

Corcept Therapeutics is coming under pressure this morning after Teva Pharmaceutical Industries (TEVA) submitted a new drug application for a generic version of the company's Korlym drug.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT